Choueiri, T. K., Albigès, L., McDermott, D. F., Hammers, H. J., Escudier, B., Burotto, M., Plimack, E. R., Porta, C., George, S., Powles, T.
, Donskov, F., Atkins, M. B., Gurney, H., Kollmannsberger, C. K., Grimm, M. O., Barrios, C., Castellano, D., Grünwald, V., Tomita, Y. ... Motzer, R. J. (2026).
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial☆.
Annals of Oncology. Advance online publication.
https://doi.org/10.1016/j.annonc.2026.02.017
Vissing, J., Zimprich, F., Atula, S., Chan, A.
, Andersen, H., Topakian, R., Tannemaat, M. R., Weber, K. P., Cetin, H., Neuwirth, C., Kuusisto, H. & Loescher, W. N. (2026).
A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis.
Therapeutic Advances in Neurological Disorders,
19.
https://doi.org/10.1177/17562864261429176